October 15, 2009
Interim data with donepezil administered to patients in the Mayo Acute Stroke Trial to Enhance Recovery (MASTER) supports advancement into stage 2, according to a report presented here at the American Neurological Association (ANA) 134th Annual Meeting…  The objective of this study was to develop donepezil hydrochloride as a novel pharmacotherapy to enhance poststroke […]